- Spain CIMA (Spanish): search for “somatostatin” (external search; text not reproduced)
External search; text not reproduced. Check the Philippine package insert in the products table.
Dosing: Altered kidney function
No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.
Kidney-specific guidance from renalcarematters.com: in preparation.
Dosage forms
Philippines
- Lyophilized powder for injection: 3 mg
- Powder for injection: 3 mg
Registered products in the Philippines
2 products registered with the Food and Drug Administration (FDA) Philippines list Somatostatin as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.
| Package insert | |||||||
|---|---|---|---|---|---|---|---|
SomaritinSomatostatin (as acetate) | 3 mg Lyophilized Powder for Injection (IV)Type I Glass Vial with bromobutyl rubber closure and aluminum seal + 2 mL-capacity Type I Glass Ampoule x 1 mL Sodium Chloride (as solvent) (Box of 1's) | RxVAT-exempt | Anfarm Hellas S.A.Greece | Ambicare Pharmaceuticals Inc. | DRP-7980 | Oct 10, 2028 | |
SomasetSomatostatin (as acetate) | 3 mg Powder for Injection (IV)Type I Glass Vial with bromobutyl rubber closure and aluminum seal + 2 mL-capacity Type I Glass Ampoule x 1 mL Sodium Chloride (as solvent) (Box of 1's) | RxVAT-exempt | Anfarm Hellas S.A.Greece | The Cathay Drug Co., Inc.Importer: Ambicare Pharmaceuticals Inc. | DRP-7980-01 | Oct 10, 2028 |
Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.
Formulary and pricing (Philippines)
Government price references
| Preparation | Price (PHP) | Unit | Type |
|---|---|---|---|
| Somatostatin 3 mg Vial | ₱4,209.91–₱5,598.00Reference ₱4,390.00 | per vial | DPRI procurement range |
| Somatostatin 250 mcg Vial | ₱630.42–₱798.00Reference ₱630.42 | per vial | DPRI procurement range |
Range = lowest-highest procurement price (highest usable only in GIDA areas); reference_price = 2021 DPRI ceiling (median)
These are government procurement and reimbursement references, not retail prices. Sources:
- DOH Drug Price Reference Index (DPRI) 2021, 9th edition (as of September 17, 2021); https://caro.doh.gov.ph/wp-content/uploads/2021/09/2021DPRI-as-of-9-17-2021.pdf, as of September 17, 2021
Formulary and coverage
| Philippine National Formulary | Listed as Somatostatin |
| PNF listing | Inj.: 250 microgram and 3 mg ampul/vial (IV, IV infusion)Restrictions: Specific expertise, diagnostic precision, or special equipment required for proper use (PNF code 1); Limited indications or narrow spectrum of activity (PNF code 2) |
| PhilHealth GAMOT | No |
Sources:
- PNF Essential Medicines List, 8th ed. (as of November 2, 2022), DOH; https://www.philhealth.gov.ph/partners/providers/pdf/PNF-EML_11022022.pdf, as of November 2, 2022
Check availability
Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.
References
- Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph
- PNF Essential Medicines List, 8th ed. (as of November 2, 2022), DOH; https://www.philhealth.gov.ph/partners/providers/pdf/PNF-EML_11022022.pdf
- DOH Drug Price Reference Index (DPRI) 2021, 9th edition (as of September 17, 2021); https://caro.doh.gov.ph/wp-content/uploads/2021/09/2021DPRI-as-of-9-17-2021.pdf
This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.
Last updated: .
